Unknown

Dataset Information

0

What is the optimal first-line treatment for advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer?

ABSTRACT:

SUBMITTER: Sekine I 

PROVIDER: S-EPMC5465132 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer.
| S-EPMC8154809 | biostudies-literature
Unknown Cost-Effectiveness of Lorlatinib as a First-Line Therapy for Untreated Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer.
| S-EPMC8203315 | biostudies-literature
Unknown Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients.
| S-EPMC7472246 | biostudies-literature
Unknown P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
| S-EPMC4739423 | biostudies-literature
Unknown Pharmacometric analyses of alectinib to facilitate approval of the optimal dose for the first-line treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer.
| S-EPMC8592510 | biostudies-literature
Unknown Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer.
| S-EPMC5627646 | biostudies-literature
Unknown Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond.
| S-EPMC3232174 | biostudies-literature
Unknown Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.
| S-EPMC6778633 | biostudies-literature
Unknown Is there a benefit of first- or second-line crizotinib in locally advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer? a meta-analysis.
| S-EPMC5348378 | biostudies-literature
Unknown Is alectinib the new first line therapy in ALK-rearranged advanced non-small cell lung cancer?
| S-EPMC6072953 | biostudies-literature